| Stratum Holdings CEO Issues Shareholder Letter Highlighting Progress in AI Infrastructure Transformation |
Globe Newswire |
11/02 |
08:00 |
| Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response |
Globe Newswire |
11/02 |
08:00 |
| Innventure Announces Formation of Strategic Review Committee to Review Range of Capital Strategies |
Globe Newswire |
11/02 |
08:00 |
| The Office Gurus Announces Acquisition of Select VoiceCom, Expanding Global Delivery Capabilities in the Philippines |
Globe Newswire |
11/02 |
08:00 |
| Former Microsoft and Cisco Security Executive Edna Conway Joins Known Advisory Council |
Globe Newswire |
11/02 |
08:00 |
| STMicroelectronics announces status of common share repurchase program |
Globe Newswire |
11/02 |
08:00 |
| Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference |
Globe Newswire |
11/02 |
08:00 |
| Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026 |
Globe Newswire |
11/02 |
08:00 |
| DeFi Development Corp. Surpasses 2.6 Million SOL as CHAD’s 14% Annualized Dividend Rate Takes Effect |
Globe Newswire |
11/02 |
08:00 |
| New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation |
Globe Newswire |
11/02 |
08:00 |
| RANE Partners with ISM to Help Global Supply Chain Professionals Get Ahead of Disruption |
Globe Newswire |
11/02 |
08:00 |
| Radiopharm Theranostics Reports Business Update |
Globe Newswire |
11/02 |
08:00 |
| Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026 |
Globe Newswire |
11/02 |
08:00 |
| CytomX Therapeutics to Present at Upcoming November Investor Conferences |
Globe Newswire |
11/02 |
08:00 |
| A3P Biomedical appoints Matt Franklin as President, North America to accelerate US market access for Stockholm3 |
Globe Newswire |
11/02 |
08:00 |
| Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China |
Globe Newswire |
11/02 |
08:00 |
| Syntec Optics (Nasdaq: OPTX) Secures 25% Order Increase for Advanced Space Reconnaissance |
Globe Newswire |
11/02 |
08:00 |
| Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-‘286) Following Interim Futility Analysis |
Globe Newswire |
11/02 |
08:00 |
| Magna to Host Investor Day on November 11, 2026 |
Globe Newswire |
11/02 |
08:00 |
| Menlo Microsystems Appoints John B. Kennedy as Chief Financial Officer |
Globe Newswire |
11/02 |
08:00 |
| Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective |
Globe Newswire |
11/02 |
08:00 |
| New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud |
Globe Newswire |
11/02 |
08:00 |
| UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer |
Globe Newswire |
11/02 |
08:00 |
| Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data |
Globe Newswire |
11/02 |
08:00 |
| AI Innovation Takes Center Stage at PowerPlan ELEVATE 2026 |
Globe Newswire |
11/02 |
07:55 |
